- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
452
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
452 companies
EZZ Life Science Holdings
Market Cap: AU$74.3m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$1.58
7D
-6.8%
1Y
215.0%
JBM (Healthcare)
Market Cap: HK$1.5b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$1.81
7D
-0.5%
1Y
96.7%
SSY Group
Market Cap: HK$9.7b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$3.29
7D
2.2%
1Y
-29.1%
Elicera Therapeutics
Market Cap: SEK 87.7m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 2.50
7D
4.6%
1Y
70.1%
Tianjin Chase Sun PharmaceuticalLtd
Market Cap: CN¥10.7b
Engages in the research and development, production, and sale of various pharmaceutical products in China and internationally.
300026
CN¥3.56
7D
0.6%
1Y
-13.6%
Pak Fah Yeow International
Market Cap: HK$679.4m
An investment holding, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.18
7D
1.4%
1Y
7.4%
Hyphens Pharma International
Market Cap: S$88.0m
Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
1J5
S$0.28
7D
0%
1Y
1.8%
Lipocine
Market Cap: US$17.9m
A clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders.
LPCN
US$3.50
7D
9.4%
1Y
-22.0%
NeuroScientific Biopharmaceuticals
Market Cap: AU$5.9m
Engages in the research and development of novel peptide-based pharmaceutical products.
NSB
AU$0.041
7D
20.6%
1Y
-12.8%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.8b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.23
7D
0.8%
1Y
-8.2%
Kotra Industries Berhad
Market Cap: RM 585.8m
An investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia.
KOTRA
RM 3.95
7D
-4.8%
1Y
-16.0%
Rhone Ma Holdings Berhad
Market Cap: RM 142.7m
An investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia.
RHONEMA
RM 0.65
7D
0%
1Y
-1.5%
Sino Biopharmaceutical
Market Cap: HK$63.6b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$3.50
7D
4.5%
1Y
7.0%
Lipigon Pharmaceuticals
Market Cap: SEK 36.2m
Develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.24
7D
43.7%
1Y
-33.2%
Puma Biotechnology
Market Cap: US$164.7m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$3.24
7D
-5.4%
1Y
-30.5%
Precigen
Market Cap: US$527.2m
Operates as a discovery and clinical-stage biopharmaceutical company that develops gene and cell therapies using precision technology to target diseases in therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases.
PGEN
US$1.78
7D
0.6%
1Y
28.1%
Kiora Pharmaceuticals
Market Cap: US$9.7m
A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases in the United States.
KPRX
US$3.29
7D
3.1%
1Y
-39.1%
Medical Developments International
Market Cap: AU$71.0m
Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.
MVP
AU$0.63
7D
7.7%
1Y
1.6%
Radiopharm Theranostics
Market Cap: AU$72.4m
Engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs.
RAD
AU$0.031
7D
-3.1%
1Y
-48.3%
Evaxion Biotech
Market Cap: US$11.2m
A clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies.
EVAX
US$1.87
7D
2.2%
1Y
-87.9%
Newbury Pharmaceuticals
Market Cap: SEK 81.0m
Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.
NEWBRY
SEK 3.34
7D
0.6%
1Y
-12.8%
Arterra Bioscience
Market Cap: €14.0m
A research-based biotech company, engages in the research and development of various ingredients and natural solutions.
ARBS
€2.10
7D
1.0%
1Y
0%
Unicycive Therapeutics
Market Cap: US$60.7m
A biotechnology company, develops treatments for various medical conditions in the United States.
UNCY
US$0.58
7D
7.0%
1Y
-59.4%
Citius Pharmaceuticals
Market Cap: US$12.9m
A biopharmaceutical company, focuses on the development and commercialization of critical care products.
CTXR
US$1.53
7D
-3.2%
1Y
-91.5%
Aelis Farma
Market Cap: €16.9m
A clinical-stage biotechnology company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders.
AELIS
€1.24
7D
-12.7%
1Y
-90.7%
Biofrontera
Market Cap: US$7.2m
A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
BFRI
US$1.01
7D
14.8%
1Y
-19.8%
aTyr Pharma
Market Cap: US$333.3m
A biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States.
ATYR
US$4.01
7D
29.4%
1Y
105.1%
Adagene
Market Cap: US$78.4m
A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers.
ADAG
US$1.81
7D
-9.0%
1Y
-37.6%
Acrux
Market Cap: AU$9.3m
Engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.
ACR
AU$0.023
7D
-14.8%
1Y
-54.0%
InflaRx
Market Cap: US$70.1m
A clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States.
IFRX
US$1.22
7D
2.5%
1Y
-18.7%
Apex Healthcare Berhad
Market Cap: RM 1.5b
An investment holding company, engages in the development, manufacture, marketing, distribution, and wholesaling of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally.
AHEALTH
RM 2.06
7D
-5.1%
1Y
-30.6%
Biovica International
Market Cap: SEK 97.8m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.
BIOVIC B
SEK 1.00
7D
-44.1%
1Y
-55.9%
Arctic Bioscience
Market Cap: NOK 96.4m
A clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds.
ABS
NOK 3.80
7D
0%
1Y
-58.1%
Decibel Cannabis
Market Cap: CA$40.4m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.07
7D
0%
1Y
-41.7%
Jerusalem Pharmaceuticals
Market Cap: US$67.5m
Develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally.
JPH
US$3.75
7D
0.5%
1Y
-1.3%
LungLife AI
Market Cap: UK£383.2k
A diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China.
LLAI
UK£0.013
7D
-10.7%
1Y
-95.6%